Table 2 Demographics characteristics of vitiligo patients
| Â | Case | Control | |
|---|---|---|---|
Age/Years (MEAN ±SD) Group 1 (< 18 years) (MEAN ± SD) Group 2 (> 18 years) (MEAN ± SD) | 33.23 ± 16.98 11.87 ± 4.14 39.97 ± 13.54 | 33.86 ± 15.9 12.37 ± 4.52 38.90 ± 13.18 | |
Age of Onset/ Years (MEAN ± SD) | 26.04 ± 14.83 |  | |
Gender | Male (N/%) | 45/45% | Â |
Female (N/%) | 55/55% | Â | |
Course of disease | Regressive (N/%) | 6/6% | Â |
Progressive (N/%) | 90 /90% | Â | |
Stable (N/%) | 4/4% | Â | |
Psychic trauma | Yes (N/%) | 26 /26% | Â |
No (N/%) | 74/74% | Â | |
Autoimmune diseases (AIDs) | Yes (N/%) | 0/0% | Â |
No (N/%) | 100/100% | Â | |
Alopecia | Yes (N/%) | 14/14% | Â |
No (N/%) | 86/86% | Â | |
Family history | Yes (N/%) | 8/8% | Â |
No (N/%) | 92/92% | Â | |
Family history of AIDs | Yes (N/%) | 9/9% | Â |
No (N/%) | 91/91% | Â | |
Remission | Yes (N/%) | 63/63% | Â |
No (N/%) | 37/37% | Â | |
Phototherapy | Yes (N/%) | 99/99% | Â |
No (N/%) | 1/1% | Â | |
Type | Segmental (N/%) | 17/17% | Â |
Non-Segmental (N/%) | 83/83% | Â | |
VIDA score | 0 | 22/22% | Â |
1 | 13/13% | Â | |
2 | 14/14% | Â | |
3 | 15/15% | Â | |
4 | 36/36% | Â | |